Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 4, Issue 4, Pages 495-511Publisher
ELSEVIER
DOI: 10.1016/j.intimp.2004.02.001
Keywords
asthma; allergic disease; omalizumab
Categories
Funding
- NHLBI NIH HHS [R01-HL073349, R01-HL070885] Funding Source: Medline
Ask authors/readers for more resources
The search for new treatments of asthma or any other disease for that matter is an infinite exercise. The scope for discovering new forms of treatment has increased now more than ever due to a better understanding of the molecular pathogenesis of the disease. Regulation of biomolecular or immunological events could occur at numerous points in the disease pathogenesis. This review describes the strategies to regulate the inappropriate immune responses that are elicited after exposure to an allergen. One such successful therapy is treatment with omalizumab, the anti-IgE antibody. Other therapies include cytokine antagonists, transcription factor antagonists, immunostimulatory DNA therapy, cytokine therapy and anti-T cell strategies. All these agents have been shown to be promising and could serve as an alternative approach to the treatment of asthma and maybe other allergic diseases. (C) 2004 Elsevier B.V All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available